Keenan Greg sold AUPH
August 1, 2025 · Form 4 insider transaction
Keenan Greg sold 20,000 shares of Aurinia Pharmaceuticals Inc. at $10.50 per share, a transaction worth $210.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
20,000
Price
$10.50
Total value
$210.0K
InsiderKeenan Greg
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 1, 2025
Filing dateAugust 5, 2025
Shares owned after133,484
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.48 to $10.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.